Rank | Gene Set | Z-score |
---|---|---|
1 | epidermis development (GO:0008544) | 8.35918056 |
2 | keratinocyte proliferation (GO:0043616) | 7.83086017 |
3 | detection of bacterium (GO:0016045) | 6.85985709 |
4 | * keratinization (GO:0031424) | 6.82998792 |
5 | hair cycle (GO:0042633) | 6.50917551 |
6 | molting cycle (GO:0042303) | 6.50917551 |
7 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.39799363 |
8 | detection of other organism (GO:0098543) | 6.25457987 |
9 | establishment of skin barrier (GO:0061436) | 5.99701267 |
10 | gap junction assembly (GO:0016264) | 5.87172874 |
11 | lipoxygenase pathway (GO:0019372) | 5.81446866 |
12 | desmosome organization (GO:0002934) | 5.64506805 |
13 | regulation of water loss via skin (GO:0033561) | 5.58105160 |
14 | establishment of tissue polarity (GO:0007164) | 5.21827847 |
15 | establishment of planar polarity (GO:0001736) | 5.21827847 |
16 | regulation of natural killer cell differentiation (GO:0032823) | 5.18909389 |
17 | intermediate filament cytoskeleton organization (GO:0045104) | 4.99647204 |
18 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 4.94123061 |
19 | negative regulation of interferon-gamma production (GO:0032689) | 4.84662966 |
20 | intermediate filament-based process (GO:0045103) | 4.83314273 |
21 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.81046033 |
22 | L-phenylalanine metabolic process (GO:0006558) | 4.81046033 |
23 | keratinocyte development (GO:0003334) | 4.69793880 |
24 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.65819774 |
25 | cysteine metabolic process (GO:0006534) | 4.63553956 |
26 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 4.62737960 |
27 | L-phenylalanine catabolic process (GO:0006559) | 4.54894282 |
28 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.54894282 |
29 | sequestering of metal ion (GO:0051238) | 4.38146302 |
30 | positive regulation of epidermis development (GO:0045684) | 4.35600358 |
31 | sulfur amino acid catabolic process (GO:0000098) | 4.31452620 |
32 | hemidesmosome assembly (GO:0031581) | 4.30474008 |
33 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 4.28551103 |
34 | surfactant homeostasis (GO:0043129) | 4.22995693 |
35 | positive regulation of epidermal cell differentiation (GO:0045606) | 4.22730142 |
36 | negative regulation of keratinocyte proliferation (GO:0010839) | 4.17183156 |
37 | eyelid development in camera-type eye (GO:0061029) | 4.12188860 |
38 | glyoxylate metabolic process (GO:0046487) | 4.10549751 |
39 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 4.07220913 |
40 | aromatic amino acid family catabolic process (GO:0009074) | 4.07098280 |
41 | serine family amino acid catabolic process (GO:0009071) | 4.06909495 |
42 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 4.04446775 |
43 | glycine metabolic process (GO:0006544) | 4.03917999 |
44 | epithelium development (GO:0060429) | 3.90861067 |
45 | kynurenine metabolic process (GO:0070189) | 3.90818068 |
46 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.88426296 |
47 | lysine catabolic process (GO:0006554) | 3.88280306 |
48 | lysine metabolic process (GO:0006553) | 3.88280306 |
49 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.85219394 |
50 | serine family amino acid metabolic process (GO:0009069) | 3.79729946 |
51 | urea metabolic process (GO:0019627) | 3.77949310 |
52 | urea cycle (GO:0000050) | 3.77949310 |
53 | transepithelial transport (GO:0070633) | 3.77895995 |
54 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.72689254 |
55 | indole-containing compound catabolic process (GO:0042436) | 3.71855573 |
56 | indolalkylamine catabolic process (GO:0046218) | 3.71855573 |
57 | tryptophan catabolic process (GO:0006569) | 3.71855573 |
58 | negative regulation of fibrinolysis (GO:0051918) | 3.69200118 |
59 | regulation of cholesterol homeostasis (GO:2000188) | 3.69155802 |
60 | multicellular organismal water homeostasis (GO:0050891) | 3.68368511 |
61 | high-density lipoprotein particle remodeling (GO:0034375) | 3.63152388 |
62 | detection of external biotic stimulus (GO:0098581) | 3.57207614 |
63 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.55895665 |
64 | regulation of gene silencing by miRNA (GO:0060964) | 3.55895665 |
65 | regulation of gene silencing by RNA (GO:0060966) | 3.55895665 |
66 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 3.54302575 |
67 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.48840655 |
68 | homocysteine metabolic process (GO:0050667) | 3.48796216 |
69 | serine family amino acid biosynthetic process (GO:0009070) | 3.47734731 |
70 | tryptophan metabolic process (GO:0006568) | 3.47098217 |
71 | negative regulation of interleukin-17 production (GO:0032700) | 3.46890368 |
72 | protein carboxylation (GO:0018214) | 3.46882305 |
73 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.46882305 |
74 | chemical homeostasis within a tissue (GO:0048875) | 3.46675740 |
75 | urate metabolic process (GO:0046415) | 3.45988064 |
76 | linoleic acid metabolic process (GO:0043651) | 3.44785366 |
77 | phospholipid efflux (GO:0033700) | 3.43485154 |
78 | nitrogen cycle metabolic process (GO:0071941) | 3.43016408 |
79 | hair follicle morphogenesis (GO:0031069) | 3.42627480 |
80 | regulation of monocyte chemotaxis (GO:0090025) | 3.41499918 |
81 | regulation of protein activation cascade (GO:2000257) | 3.41492425 |
82 | fibrinolysis (GO:0042730) | 3.41343299 |
83 | amino-acid betaine metabolic process (GO:0006577) | 3.40025912 |
84 | * keratinocyte differentiation (GO:0030216) | 3.36155545 |
85 | positive regulation of T cell chemotaxis (GO:0010820) | 3.35742836 |
86 | regulation of T cell chemotaxis (GO:0010819) | 3.35742836 |
87 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.35119607 |
88 | alpha-linolenic acid metabolic process (GO:0036109) | 3.34775860 |
89 | water homeostasis (GO:0030104) | 3.34001462 |
90 | regulation of keratinocyte differentiation (GO:0045616) | 3.33832307 |
91 | atrioventricular valve morphogenesis (GO:0003181) | 3.33506606 |
92 | imidazole-containing compound metabolic process (GO:0052803) | 3.29790688 |
93 | polarized epithelial cell differentiation (GO:0030859) | 3.28753929 |
94 | regulation of epidermis development (GO:0045682) | 3.28376988 |
95 | cellular modified amino acid catabolic process (GO:0042219) | 3.27914077 |
96 | regulation of fibrinolysis (GO:0051917) | 3.26922790 |
97 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.25333820 |
98 | phosphatidylserine metabolic process (GO:0006658) | 3.24852688 |
99 | embryonic process involved in female pregnancy (GO:0060136) | 3.21758282 |
100 | bile acid biosynthetic process (GO:0006699) | 3.20493633 |
101 | regulation of complement activation (GO:0030449) | 3.19164483 |
102 | proline metabolic process (GO:0006560) | 3.18281311 |
103 | regulation of keratinocyte proliferation (GO:0010837) | 3.18123163 |
104 | complement activation, alternative pathway (GO:0006957) | 3.16356180 |
105 | skin morphogenesis (GO:0043589) | 3.16141208 |
106 | reverse cholesterol transport (GO:0043691) | 3.13586097 |
107 | * epithelial cell differentiation (GO:0030855) | 3.12014283 |
108 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.11879686 |
109 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.11685371 |
110 | proline biosynthetic process (GO:0006561) | 3.09199308 |
111 | alpha-amino acid catabolic process (GO:1901606) | 3.08880934 |
112 | response to UV-B (GO:0010224) | 3.08337084 |
113 | plasma lipoprotein particle clearance (GO:0034381) | 3.05592154 |
114 | response to phenylpropanoid (GO:0080184) | 3.03573352 |
115 | establishment of apical/basal cell polarity (GO:0035089) | 3.03511081 |
116 | aromatic amino acid family metabolic process (GO:0009072) | 3.03503737 |
117 | cell-substrate junction assembly (GO:0007044) | 3.03430989 |
118 | ceramide biosynthetic process (GO:0046513) | 3.02695696 |
119 | regulation of hippo signaling (GO:0035330) | 3.02635647 |
120 | regulation of ruffle assembly (GO:1900027) | 3.02399345 |
121 | L-ascorbic acid metabolic process (GO:0019852) | 3.01958866 |
122 | negative regulation of sterol transport (GO:0032372) | 3.01880405 |
123 | negative regulation of cholesterol transport (GO:0032375) | 3.01880405 |
124 | glutamate metabolic process (GO:0006536) | 3.01789980 |
125 | detection of biotic stimulus (GO:0009595) | 3.00447142 |
126 | primary alcohol catabolic process (GO:0034310) | 3.00022054 |
127 | epithelial cell-cell adhesion (GO:0090136) | 2.99446613 |
128 | acylglycerol homeostasis (GO:0055090) | 2.96865951 |
129 | triglyceride homeostasis (GO:0070328) | 2.96865951 |
130 | regulation of triglyceride catabolic process (GO:0010896) | 2.96465592 |
131 | ethanol oxidation (GO:0006069) | 2.94545646 |
132 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.93371890 |
133 | ectoderm development (GO:0007398) | 2.93000758 |
134 | cellular amino acid catabolic process (GO:0009063) | 2.91779315 |
135 | acetyl-CoA metabolic process (GO:0006084) | 2.91513401 |
136 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.91377646 |
137 | * peptide cross-linking (GO:0018149) | 2.87787156 |
138 | regulation of epidermal cell differentiation (GO:0045604) | 2.86511650 |
139 | interferon-gamma secretion (GO:0072643) | 2.85861240 |
140 | bile acid metabolic process (GO:0008206) | 2.85850099 |
141 | plasma lipoprotein particle remodeling (GO:0034369) | 2.85515921 |
142 | protein-lipid complex remodeling (GO:0034368) | 2.85515921 |
143 | macromolecular complex remodeling (GO:0034367) | 2.85515921 |
144 | drug catabolic process (GO:0042737) | 2.85478820 |
145 | drug transmembrane transport (GO:0006855) | 2.83025094 |
146 | maternal placenta development (GO:0001893) | 2.77174045 |
147 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.76709941 |
148 | intermediate filament organization (GO:0045109) | 2.76364139 |
149 | folic acid metabolic process (GO:0046655) | 2.75116605 |
150 | low-density lipoprotein particle clearance (GO:0034383) | 2.75001029 |
151 | tetrahydrofolate metabolic process (GO:0046653) | 2.74838631 |
152 | regulation of cholesterol esterification (GO:0010872) | 2.74630535 |
153 | aspartate family amino acid catabolic process (GO:0009068) | 2.74608506 |
154 | hormone catabolic process (GO:0042447) | 2.73293198 |
155 | cholesterol homeostasis (GO:0042632) | 2.72064420 |
156 | sterol homeostasis (GO:0055092) | 2.71253877 |
157 | alditol phosphate metabolic process (GO:0052646) | 2.67145759 |
158 | cell communication involved in cardiac conduction (GO:0086065) | 2.65922848 |
159 | lateral sprouting from an epithelium (GO:0060601) | 2.63451173 |
160 | hypotonic response (GO:0006971) | 2.60267773 |
161 | regulation of natural killer cell activation (GO:0032814) | 2.57962534 |
162 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.55832207 |
163 | regulation of axon regeneration (GO:0048679) | 2.55214537 |
164 | regulation of neuron projection regeneration (GO:0070570) | 2.55214537 |
165 | intestinal epithelial cell development (GO:0060576) | 2.54165192 |
166 | protein localization to endosome (GO:0036010) | 2.53266667 |
167 | regulation of establishment of planar polarity (GO:0090175) | 2.50358130 |
168 | defense response to fungus (GO:0050832) | 2.49944908 |
169 | skin development (GO:0043588) | 2.47718722 |
170 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.46810435 |
171 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.43450748 |
172 | cellular component disassembly involved in execution phase of apoptosis (GO:0006921) | 2.42683299 |
173 | wound healing (GO:0042060) | 2.38591041 |
174 | apical protein localization (GO:0045176) | 2.38041364 |
175 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.37965024 |
176 | hair cell differentiation (GO:0035315) | 2.37450730 |
177 | endosome organization (GO:0007032) | 2.33038547 |
178 | phospholipid catabolic process (GO:0009395) | 2.32854164 |
179 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.32778819 |
180 | molting cycle process (GO:0022404) | 2.31775283 |
181 | hair cycle process (GO:0022405) | 2.31775283 |
182 | cardiac conduction (GO:0061337) | 2.28123843 |
183 | * epidermal cell differentiation (GO:0009913) | 10.4270306 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.54339905 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.22679264 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.79452277 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.56353789 |
5 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.95700515 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.77110474 |
7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.74224580 |
8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.71341856 |
9 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.52480261 |
10 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.52480261 |
11 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.52480261 |
12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.51785245 |
13 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.44191047 |
14 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.32944479 |
15 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.31829790 |
16 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.18740448 |
17 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.15674755 |
18 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.15651255 |
19 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.12127040 |
20 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.01339599 |
21 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.97989340 |
22 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.93887836 |
23 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.91837950 |
24 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.83651527 |
25 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.80709868 |
26 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.79937183 |
27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.79925257 |
28 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.76507460 |
29 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.74873716 |
30 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.66609065 |
31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.65581712 |
32 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.63859026 |
33 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.62758652 |
34 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.62291298 |
35 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.61108651 |
36 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.61064142 |
37 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.56499727 |
38 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.55701949 |
39 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.55045350 |
40 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.52881557 |
41 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.52214972 |
42 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.51931630 |
43 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.51093582 |
44 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.50084289 |
45 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.45117863 |
46 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.44983253 |
47 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.44456221 |
48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.42927080 |
49 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.41807809 |
50 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.41411420 |
51 | ATF3_27146783_Chip-Seq_COLON_Human | 1.41210191 |
52 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.36137471 |
53 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.35539363 |
54 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.34849097 |
55 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.33801599 |
56 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.33142280 |
57 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.32736087 |
58 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.31369396 |
59 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29624033 |
60 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.29109577 |
61 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.28479375 |
62 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.28205662 |
63 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.27232804 |
64 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.26972144 |
65 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26391621 |
66 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.25502792 |
67 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.20964051 |
68 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.20824184 |
69 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20507127 |
70 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.19409027 |
71 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.18699789 |
72 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.18170212 |
73 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18140446 |
74 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.17685921 |
75 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.16319705 |
76 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.15895001 |
77 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13863253 |
78 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.13757906 |
79 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.12740161 |
80 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.12639689 |
81 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.11128712 |
82 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.08647768 |
83 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.07855688 |
84 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.07312267 |
85 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.07195311 |
86 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.06814864 |
87 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06167861 |
88 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.05642743 |
89 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.04954397 |
90 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.03411498 |
91 | MYC_22102868_ChIP-Seq_BL_Human | 1.03259668 |
92 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.02962983 |
93 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.02948502 |
94 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.02868696 |
95 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02512904 |
96 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.01947949 |
97 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01436619 |
98 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00829172 |
99 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.00077991 |
100 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.99912252 |
101 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.99852343 |
102 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.99758652 |
103 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99199514 |
104 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.98498220 |
105 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.98498220 |
106 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98363001 |
107 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.97991258 |
108 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.97415598 |
109 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96911280 |
110 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96800808 |
111 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.96234348 |
112 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.95734210 |
113 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.95472890 |
114 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94537907 |
115 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.94274015 |
116 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.93945889 |
117 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.93011805 |
118 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92476660 |
119 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91877719 |
120 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.91835087 |
121 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90969170 |
122 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90188447 |
123 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.89326815 |
124 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.89188838 |
125 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.88964946 |
126 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88943269 |
127 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.88896704 |
128 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.87081335 |
129 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.86241105 |
130 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.86071208 |
131 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85960605 |
132 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.85950779 |
133 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.84887608 |
134 | KDM2B_26808549_Chip-Seq_K562_Human | 0.83915864 |
135 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.83915224 |
136 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83717604 |
137 | CJUN_26792858_Chip-Seq_BT549_Human | 0.83478560 |
138 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.82372821 |
139 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.82263844 |
140 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.81874786 |
141 | P68_20966046_ChIP-Seq_HELA_Human | 0.81626032 |
142 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81332944 |
143 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.80239290 |
144 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.79697628 |
145 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.79063715 |
146 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.79002057 |
147 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.78427288 |
148 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.75992011 |
149 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.75506305 |
150 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74982141 |
151 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.73085249 |
152 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.71657025 |
153 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.71351931 |
154 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.69283353 |
155 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.69283353 |
156 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.68579324 |
157 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68071181 |
158 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.67365435 |
159 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.64782608 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * MP0002796_impaired_skin_barrier | 5.00826415 |
2 | MP0005360_urolithiasis | 4.03839769 |
3 | MP0010234_abnormal_vibrissa_follicle | 3.99869463 |
4 | MP0002139_abnormal_hepatobiliary_system | 3.85444613 |
5 | MP0003705_abnormal_hypodermis_morpholog | 3.50158760 |
6 | MP0005085_abnormal_gallbladder_physiolo | 3.28383244 |
7 | * MP0005501_abnormal_skin_physiology | 3.28149044 |
8 | MP0005275_abnormal_skin_tensile | 3.20082281 |
9 | MP0000579_abnormal_nail_morphology | 3.12030354 |
10 | MP0003806_abnormal_nucleotide_metabolis | 3.08410650 |
11 | MP0005365_abnormal_bile_salt | 2.90133604 |
12 | MP0004885_abnormal_endolymph | 2.59773211 |
13 | MP0003878_abnormal_ear_physiology | 2.58874853 |
14 | MP0005377_hearing/vestibular/ear_phenot | 2.58874853 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.57957774 |
16 | MP0003941_abnormal_skin_development | 2.56242146 |
17 | MP0004043_abnormal_pH_regulation | 2.56076983 |
18 | MP0002254_reproductive_system_inflammat | 2.47577675 |
19 | MP0004264_abnormal_extraembryonic_tissu | 2.38693279 |
20 | MP0003453_abnormal_keratinocyte_physiol | 2.35627078 |
21 | MP0004019_abnormal_vitamin_homeostasis | 2.24864252 |
22 | MP0008875_abnormal_xenobiotic_pharmacok | 2.23867714 |
23 | MP0002098_abnormal_vibrissa_morphology | 2.16190917 |
24 | * MP0001216_abnormal_epidermal_layer | 2.11871936 |
25 | MP0005409_darkened_coat_color | 2.06434059 |
26 | MP0002060_abnormal_skin_morphology | 1.97421282 |
27 | MP0003566_abnormal_cell_adhesion | 1.97088836 |
28 | MP0009840_abnormal_foam_cell | 1.94019119 |
29 | MP0010352_gastrointestinal_tract_polyps | 1.91286290 |
30 | MP0004947_skin_inflammation | 1.83151785 |
31 | MP0010678_abnormal_skin_adnexa | 1.81807647 |
32 | MP0000467_abnormal_esophagus_morphology | 1.80031612 |
33 | MP0000377_abnormal_hair_follicle | 1.78216144 |
34 | MP0010329_abnormal_lipoprotein_level | 1.72938545 |
35 | MP0000647_abnormal_sebaceous_gland | 1.66507083 |
36 | MP0003252_abnormal_bile_duct | 1.61462848 |
37 | MP0005332_abnormal_amino_acid | 1.58975282 |
38 | * MP0010771_integument_phenotype | 1.58005337 |
39 | MP0005083_abnormal_biliary_tract | 1.57994724 |
40 | MP0000383_abnormal_hair_follicle | 1.57342662 |
41 | MP0005451_abnormal_body_composition | 1.54430274 |
42 | MP0009053_abnormal_anal_canal | 1.49793199 |
43 | MP0005023_abnormal_wound_healing | 1.42842011 |
44 | MP0002095_abnormal_skin_pigmentation | 1.38537676 |
45 | MP0001851_eye_inflammation | 1.32435744 |
46 | MP0000427_abnormal_hair_cycle | 1.31952344 |
47 | MP0004185_abnormal_adipocyte_glucose | 1.30457861 |
48 | MP0002138_abnormal_hepatobiliary_system | 1.27100888 |
49 | MP0003011_delayed_dark_adaptation | 1.26609259 |
50 | * MP0009931_abnormal_skin_appearance | 1.26526240 |
51 | MP0000609_abnormal_liver_physiology | 1.25733654 |
52 | MP0000762_abnormal_tongue_morphology | 1.20039803 |
53 | MP0001243_abnormal_dermal_layer | 1.16338624 |
54 | MP0005076_abnormal_cell_differentiation | 1.16107372 |
55 | MP0004381_abnormal_hair_follicle | 1.13657627 |
56 | MP0001849_ear_inflammation | 1.12837719 |
57 | MP0001666_abnormal_nutrient_absorption | 1.12637318 |
58 | MP0003186_abnormal_redox_activity | 1.11992100 |
59 | MP0002234_abnormal_pharynx_morphology | 1.07656570 |
60 | MP0000367_abnormal_coat/_hair | 1.05854025 |
61 | MP0001191_abnormal_skin_condition | 1.03373654 |
62 | MP0004957_abnormal_blastocyst_morpholog | 1.01841523 |
63 | MP0005319_abnormal_enzyme/_coenzyme | 1.01769580 |
64 | MP0001881_abnormal_mammary_gland | 0.99216513 |
65 | MP0002118_abnormal_lipid_homeostasis | 0.95746745 |
66 | MP0009643_abnormal_urine_homeostasis | 0.95322507 |
67 | MP0004197_abnormal_fetal_growth/weight/ | 0.93527305 |
68 | MP0008057_abnormal_DNA_replication | 0.88198690 |
69 | MP0002086_abnormal_extraembryonic_tissu | 0.87080389 |
70 | MP0001188_hyperpigmentation | 0.85548300 |
71 | MP0003195_calcinosis | 0.83933781 |
72 | MP0005666_abnormal_adipose_tissue | 0.82322942 |
73 | MP0000627_abnormal_mammary_gland | 0.81666909 |
74 | MP0003950_abnormal_plasma_membrane | 0.78271799 |
75 | MP0003315_abnormal_perineum_morphology | 0.76985652 |
76 | MP0000598_abnormal_liver_morphology | 0.74938230 |
77 | MP0001730_embryonic_growth_arrest | 0.69856693 |
78 | MP0003718_maternal_effect | 0.68823875 |
79 | MP0005670_abnormal_white_adipose | 0.68274912 |
80 | MP0004272_abnormal_basement_membrane | 0.66747134 |
81 | MP0004782_abnormal_surfactant_physiolog | 0.66515830 |
82 | MP0000566_synostosis | 0.64814062 |
83 | MP0002136_abnormal_kidney_physiology | 0.64539790 |
84 | MP0002084_abnormal_developmental_patter | 0.63894730 |
85 | MP0002111_abnormal_tail_morphology | 0.63030727 |
86 | MP0001672_abnormal_embryogenesis/_devel | 0.61777432 |
87 | MP0005380_embryogenesis_phenotype | 0.61777432 |
88 | MP0009379_abnormal_foot_pigmentation | 0.60023846 |
89 | * MP0001784_abnormal_fluid_regulation | 0.59922718 |
90 | MP0004133_heterotaxia | 0.59382198 |
91 | MP0000678_abnormal_parathyroid_gland | 0.58857576 |
92 | MP0005248_abnormal_Harderian_gland | 0.56881878 |
93 | MP0001697_abnormal_embryo_size | 0.56188878 |
94 | MP0002088_abnormal_embryonic_growth/wei | 0.56141861 |
95 | MP0009780_abnormal_chondrocyte_physiolo | 0.56060377 |
96 | MP0005266_abnormal_metabolism | 0.55942376 |
97 | MP0003984_embryonic_growth_retardation | 0.55093891 |
98 | MP0003436_decreased_susceptibility_to | 0.54628468 |
99 | MP0000537_abnormal_urethra_morphology | 0.54586393 |
100 | MP0000470_abnormal_stomach_morphology | 0.53936634 |
101 | MP0010094_abnormal_chromosome_stability | 0.52828692 |
102 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.52740806 |
103 | MP0009763_increased_sensitivity_to | 0.52732894 |
104 | MP0000465_gastrointestinal_hemorrhage | 0.51593658 |
105 | MP0010030_abnormal_orbit_morphology | 0.51355649 |
106 | MP0000350_abnormal_cell_proliferation | 0.51165669 |
107 | MP0005375_adipose_tissue_phenotype | 0.51151263 |
108 | MP0000371_diluted_coat_color | 0.51043625 |
109 | MP0003890_abnormal_embryonic-extraembry | 0.50866862 |
110 | MP0008260_abnormal_autophagy | 0.50672802 |
111 | MP0010307_abnormal_tumor_latency | 0.50669262 |
112 | MP0000477_abnormal_intestine_morphology | 0.50010504 |
113 | MP0003119_abnormal_digestive_system | 0.49956631 |
114 | MP0003693_abnormal_embryo_hatching | 0.49728932 |
115 | MP0001915_intracranial_hemorrhage | 0.49566869 |
116 | MP0002877_abnormal_melanocyte_morpholog | 0.49565103 |
117 | MP0005395_other_phenotype | 0.49210254 |
118 | MP0002019_abnormal_tumor_incidence | 0.48687926 |
119 | MP0003638_abnormal_response/metabolism_ | 0.48019809 |
120 | MP0003111_abnormal_nucleus_morphology | 0.47531036 |
121 | MP0001340_abnormal_eyelid_morphology | 0.46518435 |
122 | MP0003755_abnormal_palate_morphology | 0.44570658 |
123 | MP0000858_altered_metastatic_potential | 0.41965278 |
124 | MP0001765_abnormal_ion_homeostasis | 0.39446206 |
125 | MP0003763_abnormal_thymus_physiology | 0.36831799 |
126 | MP0000003_abnormal_adipose_tissue | 0.36705462 |
127 | MP0005193_abnormal_anterior_eye | 0.34948659 |
128 | MP0002006_tumorigenesis | 0.34021494 |
129 | MP0001186_pigmentation_phenotype | 0.31677486 |
130 | MP0000685_abnormal_immune_system | 0.30342601 |
131 | MP0002075_abnormal_coat/hair_pigmentati | 0.28554012 |
132 | MP0001958_emphysema | 0.27616985 |
133 | MP0002282_abnormal_trachea_morphology | 0.26506493 |
134 | MP0008004_abnormal_stomach_pH | 0.25991967 |
135 | MP0009333_abnormal_splenocyte_physiolog | 0.25658050 |
136 | MP0008789_abnormal_olfactory_epithelium | 0.24810563 |
137 | MP0002177_abnormal_outer_ear | 0.24568025 |
138 | MP0005388_respiratory_system_phenotype | 0.24276181 |
139 | MP0002133_abnormal_respiratory_system | 0.24276181 |
140 | MP0003828_pulmonary_edema | 0.24031687 |
141 | MP0002009_preneoplasia | 0.22697864 |
142 | MP0002166_altered_tumor_susceptibility | 0.20701681 |
143 | MP0003300_gastrointestinal_ulcer | 0.19538858 |
144 | MP0008438_abnormal_cutaneous_collagen | 0.18876848 |
145 | MP0001485_abnormal_pinna_reflex | 0.18794407 |
146 | MP0005394_taste/olfaction_phenotype | 0.17044741 |
147 | MP0005499_abnormal_olfactory_system | 0.17044741 |
148 | MP0002249_abnormal_larynx_morphology | 0.16908311 |
149 | MP0003045_fibrosis | 0.15243757 |
150 | MP0003448_altered_tumor_morphology | 0.14383311 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of nail color (HP:0100643) | 5.63715524 |
2 | Abnormality of secondary sexual hair (HP:0009888) | 5.04760406 |
3 | Abnormality of the axillary hair (HP:0100134) | 5.04760406 |
4 | * Hypotrichosis (HP:0001006) | 5.01367197 |
5 | Parakeratosis (HP:0001036) | 4.86040812 |
6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.81325473 |
7 | Intrahepatic cholestasis (HP:0001406) | 4.55511517 |
8 | Woolly hair (HP:0002224) | 4.46808061 |
9 | Oral leukoplakia (HP:0002745) | 4.39150576 |
10 | Plantar hyperkeratosis (HP:0007556) | 4.32861846 |
11 | Right ventricular cardiomyopathy (HP:0011663) | 4.31486495 |
12 | Deep venous thrombosis (HP:0002625) | 4.21267404 |
13 | Increased IgE level (HP:0003212) | 4.21142176 |
14 | Onycholysis (HP:0001806) | 4.18940326 |
15 | Pili torti (HP:0003777) | 4.14784320 |
16 | Palmoplantar hyperkeratosis (HP:0000972) | 4.11224563 |
17 | Alopecia of scalp (HP:0002293) | 3.97590604 |
18 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.96135220 |
19 | Xanthomatosis (HP:0000991) | 3.95475358 |
20 | Palmar hyperkeratosis (HP:0010765) | 3.95065248 |
21 | Absent eyelashes (HP:0000561) | 3.80732404 |
22 | Hypobetalipoproteinemia (HP:0003563) | 3.58244339 |
23 | Abnormality of placental membranes (HP:0011409) | 3.40472469 |
24 | Amniotic constriction ring (HP:0009775) | 3.40472469 |
25 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.35266260 |
26 | Absent hair (HP:0002298) | 3.32035269 |
27 | Fragile nails (HP:0001808) | 3.25560812 |
28 | * Nail dystrophy (HP:0008404) | 3.24977488 |
29 | Sparse scalp hair (HP:0002209) | 3.19827526 |
30 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.16757425 |
31 | Milia (HP:0001056) | 3.08129761 |
32 | Hyperglycinuria (HP:0003108) | 3.05113265 |
33 | Follicular hyperkeratosis (HP:0007502) | 3.04376145 |
34 | Thick nail (HP:0001805) | 3.01058397 |
35 | Abnormal hair laboratory examination (HP:0003328) | 2.97667546 |
36 | Hyperammonemia (HP:0001987) | 2.95564411 |
37 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.88367626 |
38 | Epidermoid cyst (HP:0200040) | 2.87946577 |
39 | Hypolipoproteinemia (HP:0010981) | 2.85142414 |
40 | Ridged nail (HP:0001807) | 2.83514879 |
41 | Abnormal blistering of the skin (HP:0008066) | 2.82299269 |
42 | Abnormality of nucleobase metabolism (HP:0010932) | 2.81248803 |
43 | * Congenital ichthyosiform erythroderma (HP:0007431) | 2.81058161 |
44 | Furrowed tongue (HP:0000221) | 2.80520675 |
45 | Gout (HP:0001997) | 2.79612651 |
46 | Blepharitis (HP:0000498) | 2.77564661 |
47 | Hyperlipoproteinemia (HP:0010980) | 2.76457493 |
48 | Complement deficiency (HP:0004431) | 2.74730054 |
49 | * Ectropion (HP:0000656) | 2.74279676 |
50 | Hyperglycinemia (HP:0002154) | 2.72227380 |
51 | Spastic diplegia (HP:0001264) | 2.70701079 |
52 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.68162957 |
53 | Abnormality of glycine metabolism (HP:0010895) | 2.68162957 |
54 | Erythema (HP:0010783) | 2.63911058 |
55 | Hypoalphalipoproteinemia (HP:0003233) | 2.61013183 |
56 | Natal tooth (HP:0000695) | 2.58470763 |
57 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.57963852 |
58 | Prolonged partial thromboplastin time (HP:0003645) | 2.57411564 |
59 | Sparse eyelashes (HP:0000653) | 2.56589092 |
60 | Malnutrition (HP:0004395) | 2.55276282 |
61 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.54499652 |
62 | Abnormality of purine metabolism (HP:0004352) | 2.54240075 |
63 | Multifactorial inheritance (HP:0001426) | 2.50909037 |
64 | Conjunctival hamartoma (HP:0100780) | 2.49941401 |
65 | Autoamputation (HP:0001218) | 2.49428448 |
66 | Laryngomalacia (HP:0001601) | 2.40490815 |
67 | Esophageal varix (HP:0002040) | 2.39517314 |
68 | Abnormality of the common coagulation pathway (HP:0010990) | 2.38868081 |
69 | Distal lower limb muscle weakness (HP:0009053) | 2.38056708 |
70 | Joint hemorrhage (HP:0005261) | 2.38025907 |
71 | Abnormality of complement system (HP:0005339) | 2.37525704 |
72 | Popliteal pterygium (HP:0009756) | 2.34698200 |
73 | Advanced eruption of teeth (HP:0006288) | 2.31912482 |
74 | Hypoplastic labia majora (HP:0000059) | 2.29031248 |
75 | Ketosis (HP:0001946) | 2.27525163 |
76 | * Erythroderma (HP:0001019) | 2.25148098 |
77 | Abnormality of methionine metabolism (HP:0010901) | 2.23632638 |
78 | Anonychia (HP:0001798) | 2.22204447 |
79 | Urticaria (HP:0001025) | 2.17108155 |
80 | Abnormality of the salivary glands (HP:0010286) | 2.16883211 |
81 | Curly hair (HP:0002212) | 2.14474261 |
82 | Fat malabsorption (HP:0002630) | 2.13628610 |
83 | Hyperhidrosis (HP:0000975) | 2.12034051 |
84 | Delayed CNS myelination (HP:0002188) | 2.11568550 |
85 | Neonatal onset (HP:0003623) | 2.11153181 |
86 | Vascular calcification (HP:0004934) | 2.10227303 |
87 | Abnormality of the labia majora (HP:0012881) | 2.08926143 |
88 | Recurrent corneal erosions (HP:0000495) | 2.08503356 |
89 | Hypochromic microcytic anemia (HP:0004840) | 2.08101207 |
90 | Abnormality of the Achilles tendon (HP:0005109) | 2.07888985 |
91 | Lip pit (HP:0100267) | 2.05645336 |
92 | Acanthosis nigricans (HP:0000956) | 2.05381076 |
93 | Ependymoma (HP:0002888) | 2.04854972 |
94 | Pseudobulbar signs (HP:0002200) | 1.97852940 |
95 | Increased purine levels (HP:0004368) | 1.96994339 |
96 | Hyperuricemia (HP:0002149) | 1.96994339 |
97 | Back pain (HP:0003418) | 1.94984976 |
98 | Pustule (HP:0200039) | 1.93592161 |
99 | Keratoconjunctivitis sicca (HP:0001097) | 1.92427437 |
100 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.91540989 |
101 | Rickets (HP:0002748) | 1.89973100 |
102 | Menorrhagia (HP:0000132) | 1.88714600 |
103 | * Gangrene (HP:0100758) | 1.88520007 |
104 | Axonal loss (HP:0003447) | 1.88170047 |
105 | Carious teeth (HP:0000670) | 1.87881049 |
106 | Hyporeflexia of lower limbs (HP:0002600) | 1.84533858 |
107 | Skin ulcer (HP:0200042) | 1.83937805 |
108 | * Corneal erosion (HP:0200020) | 1.83916212 |
109 | Myocardial infarction (HP:0001658) | 1.82353955 |
110 | Cardiovascular calcification (HP:0011915) | 1.81701970 |
111 | Abnormality of the intrinsic pathway (HP:0010989) | 1.79826976 |
112 | * Dehydration (HP:0001944) | 1.79772847 |
113 | Corneal dystrophy (HP:0001131) | 1.79601233 |
114 | Selective tooth agenesis (HP:0001592) | 1.79424302 |
115 | Hypercholesterolemia (HP:0003124) | 1.78581312 |
116 | Hypergammaglobulinemia (HP:0010702) | 1.78230142 |
117 | * Palmoplantar keratoderma (HP:0000982) | 1.78051977 |
118 | Hypoglycemic coma (HP:0001325) | 1.77800566 |
119 | Hamartoma of the eye (HP:0010568) | 1.77143408 |
120 | Abnormality of hair growth rate (HP:0011363) | 1.77101972 |
121 | Slow-growing hair (HP:0002217) | 1.77101972 |
122 | * Hypohidrosis (HP:0000966) | 1.74188303 |
123 | * Pruritus (HP:0000989) | 1.74106058 |
124 | Brittle hair (HP:0002299) | 1.73331027 |
125 | Abnormal hemoglobin (HP:0011902) | 1.73137144 |
126 | Dry hair (HP:0011359) | 1.73082952 |
127 | Increased mean platelet volume (HP:0011877) | 1.72944297 |
128 | Keratoconjunctivitis (HP:0001096) | 1.72855187 |
129 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.72234856 |
130 | Paralysis (HP:0003470) | 1.72198960 |
131 | Hypoplastic toenails (HP:0001800) | 1.71633442 |
132 | Glomerulosclerosis (HP:0000096) | 1.71430788 |
133 | Abnormality of the fingernails (HP:0001231) | 1.70983327 |
134 | Abnormal cartilage morphology (HP:0002763) | 1.70147086 |
135 | Fatigable weakness (HP:0003473) | 1.70029884 |
136 | Abnormality of the neuromuscular junction (HP:0003398) | 1.70029884 |
137 | Esophageal atresia (HP:0002032) | 1.68418437 |
138 | Hepatocellular carcinoma (HP:0001402) | 1.68328697 |
139 | Hydroxyprolinuria (HP:0003080) | 1.67546809 |
140 | Abnormality of proline metabolism (HP:0010907) | 1.67546809 |
141 | Ventricular tachycardia (HP:0004756) | 1.67529539 |
142 | Fine hair (HP:0002213) | 1.67073361 |
143 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.66783058 |
144 | Oligodontia (HP:0000677) | 1.66728032 |
145 | Steatorrhea (HP:0002570) | 1.66588607 |
146 | Melanocytic nevus (HP:0000995) | 1.66574440 |
147 | Squamous cell carcinoma (HP:0002860) | 1.66051682 |
148 | Papilloma (HP:0012740) | 1.59412282 |
149 | Verrucae (HP:0200043) | 1.59412282 |
150 | Xerostomia (HP:0000217) | 1.58030530 |
151 | Recurrent bacterial skin infections (HP:0005406) | 1.56447597 |
152 | * Lack of skin elasticity (HP:0100679) | 1.55893439 |
153 | Atrophic scars (HP:0001075) | 1.49973872 |
154 | Duplicated collecting system (HP:0000081) | 1.48966194 |
155 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.43134548 |
156 | Pterygium (HP:0001059) | 1.42737008 |
157 | Labial hypoplasia (HP:0000066) | 1.42331359 |
158 | Preauricular skin tag (HP:0000384) | 1.41697256 |
159 | Villous atrophy (HP:0011473) | 1.40233093 |
160 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.40233093 |
161 | Skin pits (HP:0100276) | 1.38652307 |
162 | Ankyloglossia (HP:0010296) | 1.36147619 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA2 | 6.39704258 |
2 | ERN1 | 3.15887049 |
3 | RPS6KB2 | 3.06129338 |
4 | MAPKAPK3 | 3.01451476 |
5 | CDK12 | 2.95311434 |
6 | STK24 | 2.82156356 |
7 | BCKDK | 2.36943913 |
8 | PKN2 | 2.33698996 |
9 | STK10 | 2.07736609 |
10 | FGFR4 | 2.07348432 |
11 | TRIB3 | 2.02999013 |
12 | NEK1 | 2.00670460 |
13 | MAP3K3 | 1.95446818 |
14 | LATS1 | 1.92522851 |
15 | MST4 | 1.82762768 |
16 | MAP3K11 | 1.71490427 |
17 | FGFR3 | 1.57204289 |
18 | SGK494 | 1.55170282 |
19 | SGK223 | 1.55170282 |
20 | BLK | 1.54454126 |
21 | FER | 1.53864768 |
22 | MST1R | 1.52467002 |
23 | CDK6 | 1.49789162 |
24 | EPHA3 | 1.47411204 |
25 | SIK1 | 1.45928046 |
26 | EEF2K | 1.45786702 |
27 | MAP3K6 | 1.43280895 |
28 | PTK6 | 1.40812479 |
29 | RIPK1 | 1.36006431 |
30 | PBK | 1.35237602 |
31 | MET | 1.34125676 |
32 | LRRK2 | 1.33149830 |
33 | ICK | 1.32028159 |
34 | TTK | 1.29572855 |
35 | FLT3 | 1.26702470 |
36 | PTK2 | 1.26421271 |
37 | BMX | 1.24950854 |
38 | STK38L | 1.23987330 |
39 | PAK4 | 1.21360448 |
40 | CDK7 | 1.19666436 |
41 | LATS2 | 1.17376142 |
42 | MAP2K3 | 1.15838051 |
43 | IRAK3 | 1.15687041 |
44 | WEE1 | 1.14181002 |
45 | PRPF4B | 1.13914944 |
46 | GRK6 | 1.11561040 |
47 | ERBB4 | 1.10948855 |
48 | WNK1 | 1.10619147 |
49 | PIM1 | 1.06739231 |
50 | EPHB1 | 1.06533851 |
51 | MAP3K8 | 1.05564310 |
52 | MAP3K10 | 1.05051379 |
53 | SMG1 | 1.03057925 |
54 | MAPK11 | 1.01616594 |
55 | FGFR1 | 1.01551510 |
56 | ERBB3 | 0.98533145 |
57 | PIM2 | 0.96455990 |
58 | MAP3K1 | 0.96091923 |
59 | MTOR | 0.94055017 |
60 | CSK | 0.93753233 |
61 | IRAK1 | 0.93303631 |
62 | MATK | 0.93212207 |
63 | TYK2 | 0.92928253 |
64 | PRKCI | 0.92332264 |
65 | TGFBR2 | 0.92317233 |
66 | CDK4 | 0.91919765 |
67 | PRKD2 | 0.91737182 |
68 | MARK2 | 0.89191412 |
69 | PDGFRA | 0.85018228 |
70 | DYRK1B | 0.83378190 |
71 | NME1 | 0.83263286 |
72 | GSK3A | 0.81413546 |
73 | ALK | 0.81002816 |
74 | DDR2 | 0.80387198 |
75 | JAK3 | 0.80381722 |
76 | MAP3K13 | 0.76881419 |
77 | TTN | 0.76555143 |
78 | NEK2 | 0.72896590 |
79 | STK3 | 0.70096186 |
80 | MAP2K2 | 0.68181392 |
81 | BUB1 | 0.67565321 |
82 | IKBKB | 0.67144561 |
83 | TYRO3 | 0.67019827 |
84 | KSR2 | 0.65365807 |
85 | MAPK7 | 0.62425799 |
86 | CDC42BPA | 0.60041070 |
87 | DMPK | 0.59855928 |
88 | MAP2K6 | 0.59224666 |
89 | ARAF | 0.56604349 |
90 | RPS6KA4 | 0.56382112 |
91 | PIK3CG | 0.55818249 |
92 | PDGFRB | 0.55662213 |
93 | MAPK15 | 0.55447275 |
94 | TGFBR1 | 0.55372254 |
95 | PDK4 | 0.54945906 |
96 | PDK3 | 0.54945906 |
97 | MAP3K7 | 0.54444653 |
98 | TAOK1 | 0.53921260 |
99 | EPHB2 | 0.53710092 |
100 | AURKB | 0.53654990 |
101 | MAP3K12 | 0.50807367 |
102 | IRAK2 | 0.49238948 |
103 | AURKA | 0.48760173 |
104 | JAK2 | 0.46713920 |
105 | RPS6KA1 | 0.46216652 |
106 | AKT2 | 0.45818759 |
107 | RET | 0.45175639 |
108 | MAP3K2 | 0.44626925 |
109 | PLK1 | 0.44524050 |
110 | NTRK1 | 0.44180264 |
111 | MAPKAPK2 | 0.42951825 |
112 | CAMK1D | 0.41837052 |
113 | MAP3K9 | 0.40809455 |
114 | EGFR | 0.39845312 |
115 | CHEK2 | 0.38599924 |
116 | STK38 | 0.38205109 |
117 | SCYL2 | 0.38034111 |
118 | PDK2 | 0.36623456 |
119 | CDC7 | 0.36413432 |
120 | FGR | 0.36189727 |
121 | MAP2K1 | 0.35724385 |
122 | ACVR1B | 0.35354101 |
123 | CHEK1 | 0.35163631 |
124 | STK4 | 0.34632615 |
125 | ERBB2 | 0.34330484 |
126 | ABL2 | 0.33655169 |
127 | CSNK1E | 0.33402553 |
128 | SGK1 | 0.33311467 |
129 | DYRK3 | 0.31727114 |
130 | TRPM7 | 0.31593454 |
131 | SGK3 | 0.30657008 |
132 | CSNK1D | 0.30332154 |
133 | TBK1 | 0.29866638 |
134 | BRSK2 | 0.29166026 |
135 | IRAK4 | 0.29002861 |
136 | PRKAA2 | 0.27453804 |
137 | HCK | 0.26822750 |
138 | IKBKE | 0.26559652 |
139 | PAK2 | 0.26049212 |
140 | MYLK | 0.25980859 |
141 | TESK1 | 0.25192335 |
142 | ZAP70 | 0.24936641 |
143 | RPS6KA2 | 0.23458761 |
144 | RPS6KB1 | 0.23099809 |
145 | HIPK2 | 0.22536011 |
146 | ILK | 0.22034875 |
147 | SIK3 | 0.21540289 |
148 | LMTK2 | 0.20373207 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.32674521 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.15233980 |
3 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.11350484 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.03996000 |
5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.01420243 |
6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.96080122 |
7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.82691856 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.43880724 |
9 | VEGF signaling pathway_Homo sapiens_hsa04370 | 2.40568034 |
10 | GnRH signaling pathway_Homo sapiens_hsa04912 | 2.34829211 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.34559791 |
12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.21490772 |
13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.16598149 |
14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.11521868 |
15 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.11419022 |
16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.07125843 |
17 | Amoebiasis_Homo sapiens_hsa05146 | 2.05165419 |
18 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.04571303 |
19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.99152918 |
20 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.99040921 |
21 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.87356854 |
22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.85860965 |
23 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.83545991 |
24 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.77596319 |
25 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.77301894 |
26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.75014742 |
27 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.74583533 |
28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.73730071 |
29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.73201870 |
30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.72832557 |
31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.69243880 |
32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.66743357 |
33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.66176565 |
34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.63089917 |
35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.62679018 |
36 | Peroxisome_Homo sapiens_hsa04146 | 1.61972099 |
37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.61347932 |
38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.60382839 |
39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.58184230 |
40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.55538365 |
41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.52212273 |
42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.47961628 |
43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.47798763 |
44 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.46219969 |
45 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.45483960 |
46 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.39569774 |
47 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.39049905 |
48 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.38490690 |
49 | Retinol metabolism_Homo sapiens_hsa00830 | 1.38276542 |
50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.34902085 |
51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.31251176 |
52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.31019676 |
53 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.30278766 |
54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29761992 |
55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.29525954 |
56 | Circadian rhythm_Homo sapiens_hsa04710 | 1.29458163 |
57 | Long-term depression_Homo sapiens_hsa04730 | 1.22677591 |
58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.22312817 |
59 | Bile secretion_Homo sapiens_hsa04976 | 1.19627009 |
60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.19340729 |
61 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.17087535 |
62 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.16827109 |
63 | Sulfur relay system_Homo sapiens_hsa04122 | 1.16113508 |
64 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.15662051 |
65 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.08635560 |
66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.07525029 |
67 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.06371972 |
68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.04538176 |
69 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.00919580 |
70 | Ras signaling pathway_Homo sapiens_hsa04014 | 1.00642590 |
71 | Lysine degradation_Homo sapiens_hsa00310 | 0.98499385 |
72 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.97948706 |
73 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.97896118 |
74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.97469119 |
75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.96092172 |
76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93273264 |
77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.92013203 |
78 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90733968 |
79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89126970 |
80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.88993524 |
81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87799691 |
82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86770619 |
83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86517197 |
84 | ABC transporters_Homo sapiens_hsa02010 | 0.86396898 |
85 | Mismatch repair_Homo sapiens_hsa03430 | 0.85409385 |
86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.84032583 |
87 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.83977300 |
88 | Endocytosis_Homo sapiens_hsa04144 | 0.82677836 |
89 | Pertussis_Homo sapiens_hsa05133 | 0.82527907 |
90 | Glioma_Homo sapiens_hsa05214 | 0.82348587 |
91 | Platelet activation_Homo sapiens_hsa04611 | 0.79223619 |
92 | Renin secretion_Homo sapiens_hsa04924 | 0.77186261 |
93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74376952 |
94 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.74335954 |
95 | Shigellosis_Homo sapiens_hsa05131 | 0.73585390 |
96 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73056792 |
97 | Bladder cancer_Homo sapiens_hsa05219 | 0.71080688 |
98 | DNA replication_Homo sapiens_hsa03030 | 0.70525355 |
99 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.69812439 |
100 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.68503744 |
101 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.67896032 |
102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67833605 |
103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67267918 |
104 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.66559315 |
105 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.66454612 |
106 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.65418205 |
107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63531519 |
108 | Axon guidance_Homo sapiens_hsa04360 | 0.63396872 |
109 | Salmonella infection_Homo sapiens_hsa05132 | 0.63200745 |
110 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.63076337 |
111 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61615444 |
112 | Focal adhesion_Homo sapiens_hsa04510 | 0.60784419 |
113 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60458912 |
114 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.59992076 |
115 | Influenza A_Homo sapiens_hsa05164 | 0.58602281 |
116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58458215 |
117 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57106081 |
118 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.57065513 |
119 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56892041 |
120 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53667474 |
121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51934412 |
122 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.51733864 |
123 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51517001 |
124 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.50794848 |
125 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50418600 |
126 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50117391 |
127 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.49292977 |
128 | Phototransduction_Homo sapiens_hsa04744 | 0.48786729 |
129 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48773056 |
130 | Adherens junction_Homo sapiens_hsa04520 | 0.48279618 |
131 | Tuberculosis_Homo sapiens_hsa05152 | 0.47171697 |
132 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47091694 |
133 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46843200 |
134 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46707769 |
135 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.44982503 |
136 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.44611512 |
137 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.42885222 |
138 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.42307953 |
139 | RNA transport_Homo sapiens_hsa03013 | 0.41034234 |
140 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39784761 |
141 | Melanogenesis_Homo sapiens_hsa04916 | 0.39766837 |
142 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39131610 |
143 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.37889044 |
144 | Tight junction_Homo sapiens_hsa04530 | 0.37628077 |
145 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.36660958 |
146 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35595501 |
147 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.35507337 |
148 | Thyroid cancer_Homo sapiens_hsa05216 | 0.34187179 |
149 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.34123340 |
150 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.33455740 |
151 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33438502 |
152 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.33266909 |
153 | Insulin resistance_Homo sapiens_hsa04931 | 0.31717457 |
154 | Long-term potentiation_Homo sapiens_hsa04720 | 0.30947041 |
155 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.29354163 |
156 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.28953410 |
157 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.28650017 |
158 | Base excision repair_Homo sapiens_hsa03410 | 0.24687129 |
159 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24425835 |
160 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.22635487 |
161 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.21907917 |
162 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.21359350 |
163 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.21233753 |
164 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.19238316 |
165 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.17035869 |
166 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.16601166 |
167 | Ribosome_Homo sapiens_hsa03010 | 0.16600027 |
168 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.15081706 |
169 | Hepatitis C_Homo sapiens_hsa05160 | 0.12930258 |